Molina Healthcare, INC 8-K filings

NYSE
Molina Healthcare has been awarded a contract by the Michigan Department of Health and Human Services to provide a new dual-eligible benefit program.
NYSE
Molina Healthcare has amended its credit agreement, increasing its revolving credit facility to $1.25 billion and extending the maturity date to September 20, 2029.
NYSE
Molina Healthcare has amended its employment agreement with CEO Joseph M. Zubretsky, granting him a significant performance-based stock award to incentivize his continued leadership through 2027.
NYSE
Molina Healthcare reported a 17% increase in premium revenue for Q2 2024, but experienced a slight decrease in GAAP earnings per diluted share, while reaffirming its full-year 2024 revenue and earnings guidance.
NYSE
Molina Healthcare held its annual meeting on May 1, 2024, where stockholders elected directors, approved executive compensation, and ratified the company's auditor.
NYSE
Molina Healthcare reported a 21% increase in premium revenue for Q1 2024, but saw a slight decrease in both GAAP and adjusted earnings per diluted share compared to the same period last year, while reaffirming its full-year 2024 guidance.
NYSE
Molina Healthcare's subsidiary, Molina Healthcare of Michigan, is set to be awarded a significant Medicaid contract by the Michigan Department of Health and Human Services.
NYSE
Molina Healthcare's Virginia subsidiary was not selected for the Cardinal Care Managed Care program, impacting approximately 140,000 members.
NYSE
Molina Healthcare announced its fourth quarter and full-year 2023 financial results, exceeding expectations and providing a positive outlook for 2024 with significant revenue and earnings growth projected.